Chirals
ChiralVision is a global provider of chiral process development and enzyme immobilization services to the pharmaceutical industry. Our services include route design to advanced intermediates such as unnatural amino acids and derivatives and active pharmaceutical ingredients.
Using enzymatic technology the target optical purity for high quality chiral intermediates is >99% e.e. for single chiral centres and >98% d.e. for compounds with multiple chiral centers Various of these compounds are available as commercial product and listed below.
Products
Products:
- α-amino acids
- B-amino acids
- amines
Chirals
α-amino acids
Prod. No. | Product name [IUPAC] | Specifications | Structure |
CV0601 | D-Isoleucine [(2R,3R)-2-amino-3-methylpentanoic acid] H-D-Ile-OH | Form: C6H13NO2 MW: 131.17 Cas. No: 319-78-8 e.e.: 99 % ee d.e.: 98 % ee |
|
CV1101 | BOC-D-Isoleucine hemihydrate [BOC-(2R,3R)-2-amino-3-methylpentanoic acid] BOC-D-Ile-OH | F: C11H21NO4 .½H2O MW: 231.29 +9 Cas. No: 55721-65-8 e.e.: 99 % ee d.e.: 98 % ee |
|
CV2101 | FMOC-D-Isoleucine [FMOC-(2R,3R)-2-amino-3-methylpentanoic acid] FMOC-D-Ile-OH | Form: C21H23NO4 MW: 353.41 Cas. No: 143688-83-9 e.e.: 99 % ee d.e.: 98 % ee |
|
CV0602 | L-allo-Isoleucine [(2S,3R)-2-amino-3-methylpentanoic acid] H-allo-Ile-OH | Form: C6H13NO2 MW: 131.17 Cas. No: 1509-34-8 e.e.: 99 % ee d.e.: 98 % ee |
|
CV1102 | BOC-L-allo-Isoleucine [BOC-(2S,3R)-2-amino-3-methylpentanoic acid] BOC-allo-Ile-OH | Form: C11H21NO4 MW: 231.29 Cas. No: 35264-07-4 e.e.: 99 % ee d.e.: 98 % ee
|
|
CV2102 | FMOC-L-allo-Isoleucine [FMOC-(2S,3R)-2-amino-3-methylpentanoic acid] FMOC-allo-Ile-OH | Form: C21H23NO4 MW: 353.41 Cas. No: 251316-98-0 e.e.: 99 % ee d.e.: 98 % ee
|
|
CV0603 | D-allo-Isoleucine [(2R,3S)-2-amino-3-methylpentanoic acid] H-D-allo-Ile-OH | Form: C6H13NO2 MW: 131.17 Cas. No: 1509-35-9 e.e.: 99 % ee d.e.: 98 % ee |
|
CV1103 | BOC-D-allo-Isoleucine [BOC-(2R,3S)-2-amino-3-methylpentanoic acid] BOC-D-allo-Ile-OH | Form: C11H21NO4 MW: 231.29 Cas. No: 55780-90-0 e.e.: 99 % ee d.e.: 98 % ee |
|
CV2103 | FMOC-D-allo-Isoleucine [FMOC-(2R,3S)-2-amino-3-methylpentanoic acid] FMOC-D-allo-Ile-OH | Form: C21H23NO4 MW: 353.41 Cas. No: 118904-37-3 e.e.: 99 % ee d.e.: 98 % ee |
|
CV0604 | D-tert-Leucine [(R)-2-amino-3,3-dimethylbutanoic acid] H-tBu-D-Gly-OH H-D-Tle-OH | Form: C6H13NO2 MW: 131.17 Cas. No: 26782-71-8 e.e.: >99 % | |
CV1106 | BOC-D-tert-Leucine [BOC-(R)-2-amino-3,3-dimethylbutanoic acid] Boc-tBu-D-Gly-OH Boc-D-Tle-OH | Form: C11H21NO4 MW: 231.29 Cas. No: 124655-17-0 e.e.: >99 % |
|
CV2104 | FMOC-D-tert-Leucine [FMOC-(R)-2-amino-3,3-dimethylbutanoic acid] Fmoc-tBu-D-Gly-OH Fmoc-D-Tle-OH | Form: C21H23NO4 MW: 353.42 Cas. No: 198543-64-5 e.e.: >99 % |
|
| |||
| |||
β-amino acids | |||
Prod. No. | Product name [IUPAC] | Specifications | Structure |
CV0901 | (R)-β-phenylalanine [(R)-3-amino-3-phenylpropanoic acid] | Form: C9H11NO2 MW: 165.19 Cas. No: 13921-90-9 e.e.: 99% | |
CV1401 | BOC-(R)-β-phenylalanine [BOC-(3R)-3-amino-3-phenylpropanoic acid] | Form: C14H19NO4 MW: 265.31 Cas. No: 161024-80-2 e.e.: 99% |
|
CV2401 | FMOC-(R)-β-phenylalanine [FMOC-(3R)-3-amino-3-phenylpropanoic acid] | Form: C24H21NO4 MW: 387.44 Cas. No: 220498-02-2 e.e.: 99% |
|
CV1104 | (R)-β-phenylalanine ethyl ester [ethyl (3R)-3-amino-3-phenylpropionate] | Form: C11H15NO2 MW: 193.25 Cas. No: - e.e.: 99% |
|
CV0902 | (S)-β-phenylalanine [(S)-3-amino-3-phenylpropanoic acid] | Form: C9H11NO2 MW: 165.19 Cas. No: 40856-44-8 e.e.: >99 % | |
CV1402 | BOC-S-β-phenylalanine [BOC-(3S)-3-amino-3-phenylpropanoic acid] | Form: C14H19NO4 MW: 265.31 Cas. No: 103365-47-5 e.e.: >99 % |
|
CV2402 | FMOC-S-β-phenylalanine [FMOC-(3S)-3-amino-3-phenylpropanoic acid] | Form: C24H21NO4 MW: 387.44 Cas. No: 209252-15-3 e.e.: >99 % |
|
CV1105 | (S)-β-phenylalanine ethyl ester [ethyl (3R)-3-amino-3-phenylpropionate] | Form: C11H15NO2 MW: 193.25 Cas. No: - e.e.: >99 % |
|
CV0903 | (R)-ß-(p-chlorophenyl)alanine [(R)-3-Amino-3-(4-chloro-phenyl)-propionic acid] | Form: C9H10NO2Cl MW: 199.64 Cas. No: 131690-61-4 e.e.: >>98 % | |
CV1403 | BOC-(R)-ß-(p-chlorophenyl)alanine [BOC-(R)-3-Amino-3-(4-chloro-phenyl)-propionic acid] | Form: C14H18ClNO4 MW: 299.75 Cas. No: 479064-93-2 e.e.: >>98 % |
|
CV2403 | FMOC-(R)-ß-(p-chlorophenyl)alanine [FMOC-(R)-3-Amino-3-(4-chloro-phenyl)-propionic acid] | Form: C24H20ClNO4 MW: 421.88 Cas. No: 479064-92-1 e.e.: >>98 % |
|
CV1107 | (R)-ß-(p-chlorophenyl)alanine ethyl ester [ethyl (R)-3-Amino-3-(4-chloro-phenyl)-propionate] | Form: C11H14ClNO2 MW: 227.69 Cas. No: - e.e.: >>98 % |
|
CV0904 | (S)-ß-(p-chlorophenyl)alanine [(S)-3-Amino-3-(4-chloro-phenyl)-propionic acid] | Form: C9H10NO2Cl MW: 199.64 Cas. No: 131690-60-3 e.e.: >>98 % | |
CV1404 | BOC-(S)-ß-(p-chlorophenyl)alanine [BOC-(S)-3-Amino-3-(4-chloro-phenyl)-propionic acid] | Form: C14H18ClNO4 MW: 299.75 Cas. No: 479064-90-9 e.e.: >>98 % |
|
CV2404 | FMOC-(S)-ß-(p-chlorophenyl)alanine [FMOC-(S)-3-Amino-3-(4-chloro-phenyl)-propionic acid] | Form: C24H20ClNO4 MW: 421.88 Cas. No: 479064-91-0 e.e.: >>98 % |
|
CV1108 | (S)-ß-(p-chlorophenyl)alanine ethyl ester [ethyl (S)-3-Amino-3-(4-chloro-phenyl)-propionate] | Form: C11H14ClNO2 MW: 227.69 Cas. No: - e.e.: >>98 % |
|
CV1003 | (R)-ß-(p-methylphenyl)alanine [(R)-3-Amino-3-(4-methyl-phenyl)-propionic acid] | Form: C10H13NO2 MW: 179.22 Cas. No: 479064-87-4 e.e.: >99 % | |
CV1503 | BOC-(R)-ß-(p-methylphenyl)alanine [BOC-(R)-3-Amino-3-(4-methyl-phenyl)-propionic acid] | Form: C15H21NO4 MW: 279.33 Cas. No: 479064-97-6 e.e.: >99 % |
|
CV2503 | FMOC-(R)-ß-(p-methylphenyl)alanine [FMOC-(R)-3-Amino-3-(4-methyl-phenyl)-propionic acid] | Form: C25H23NO4 MW: 401.45 Cas. No: 479064-98-7 e.e.: >99 % |
|
CV1203 | (R)-ß-(p-methylphenyl)alanine ethyl ester [ethyl (R)-3-Amino-3-(4-methyl-phenyl)-propionate] | Form: C12H17NO2 MW: 207.27 Cas. No: - e.e.: >99 % |
|
CV1004 | (S)-ß-(p-methylphenyl)alanine [(S)-3-Amino-3-(4-methyl-phenyl)-propionic acid] | Form: C10H13NO2 MW: 179.22 Cas. No: 479065-00-4 e.e.: >99 % | |
CV1504 | BOC-(S)-ß-(p-methylphenyl)alanine [BOC-(S)-3-Amino-3-(4-methyl-phenyl)-propionic acid] | Form: C15H21NO4 MW: 279.33 Cas. No: 479064-96-5 e.e.: >99 % |
|
CV2504 | FMOC-(S)-ß-(p-methylphenyl)alanine [FMOC -(S)-3-Amino-3-(4-methyl-phenyl)-propionic acid] | Form: C25H23NO4 MW: 401.45 Cas. No: 479064-99-8 e.e.: >99 % |
|
CV1204 | (S)-ß-(p-methylphenyl)alanine ethyl ester [ethyl (S)-3-Amino-3-(4-methyl-phenyl)-propionate] | Form: C12H17NO2 MW: 207.27 Cas. No: - e.e.: >99 % |
|
CV1001 | (R)-β-(p-methoxyphenyl)alanine [(R)-3-Amino-3-(4-methoxy-phenyl)-propionic acid] | Form: C10H13NO3 MW: 195.22 Cas. No: 131690-57-8 e.e.: >99 % | |
CV1501 | BOC-(R)-β-(p-methoxyphenyl)alanine [BOC-(R)-3-Amino-3-(4-methoxy-phenyl)-propionic acid] | Form: C15H21NO5 MW: 295.33 Cas. No: 500788-87-4 e.e.: >99 % |
|
CV2501 | FMOC-(R)-β-(p-methoxyphenyl)alanine [FMOC-(R)-3-Amino-3-(4-methoxy-phenyl)-propionic acid] | Form: C25H23NO5 MW: 417.46 Cas. No: 511272-33-6 e.e.: >99 % |
|
CV1201 | (R)-β-(p-methoxyphenyl)alanine ethyl ester [ethyl (R)-3-Amino-3-(4-methoxy-phenyl)-propionate] | Form: C12H17NO3 MW: 223.27 Cas. No: - e.e.: >99 % |
|
CV1002 | (S)-β-(p-methoxyphenyl)alanine [(S)-3-Amino-3-(4-methoxy-phenyl)-propionic acid] | Form: C10H13NO3 MW: 195.22 Cas. No: 131690-56-7 e.e.: >98 % | |
CV1502 | BOC-(S)-β-(p-methoxyphenyl)alanine [BOC-(S)-3-Amino-3-(4-methoxy-phenyl)-propionic acid] | Form: C15H21NO5 MW: 295.33 Cas. No: - e.e.: >98 % |
|
CV2502 | FMOC-(S)-β-(p-methoxyphenyl)alanine [FMOC-(S)-3-Amino-3-(4-methoxy-phenyl)-propionic acid] | Form: C25H23NO5 MW: 417.46 Cas. No: - e.e.: >98 % |
|
CV1202 | (S)-β-(p-methoxyphenyl)alanine ethyl ester [ethyl (S)-3-Amino-3-(4-methoxy-phenyl)-propionate] | Form: C12H17NO3 MW: 223.27 Cas. No: - e.e.: >98 % |
|
CV0701 | (R)-3-Amino-3-(2-thienyl)-propionic acid | Form: C7H9NO2S MW: 171.22 Cas. No: 73495-10-0 | |
CV1205 | Boc-(R)-3-Amino-3-(2-thienyl)-propionic acid | Form: C12H17NO4S MW: 271.33 Cas. No: n.a. |
|
CV2201 | Fmoc-(R)-3-Amino-3-(2-thienyl)-propionic acid | Form: C22H19NO4S MW: 393.46 Cas. No: n.a. |
|
CV0702 | (S)-3-Amino-3-(2-thienyl)-propionic acid | Form: C7H9NO2S MW: 171.22 Cas. No: 131829-50-0 | |
CV1206 | Boc-(S)-3-Amino-3-(2-thienyl)-propionic acid | Form: C12H17NO4S MW: 271.33 Cas. No: n.a. |
|
CV2202 | Fmoc-(S)-3-Amino-3-(2-thienyl)-propionic acid | Form: C22H19NO4S MW: 393.46 Cas. No: n.a. |
|
CV1307 | (R)-3-Amino-3-(1-naphthyl)-propionic acid | Form: C13H13NO2 MW: 215.25 Cas. No: 775280-91-6 | |
CV1801 | Boc-(R)-3-Amino-3-(1-naphthyl)-propionic acid | Form: C18H21NO4 MW: 315.37 Cas. No: 500789-00-4 |
|
CV2801 | Fmoc-(R)-3-Amino-3-(1-naphthyl)-propionic acid | Form: C28H23NO4 MW: 437.49 Cas. No: 511272-47-2 |
|
CV1525 | ethyl (R)-3-amino-3-(1-naphthyl)-propionate | Form: C15H17NO2 MW: 243.31 Cas. No: 275826-40-9 |
|
CV1308 | (S)-3-Amino-3-(1-naphthyl)-propionic acid | Form: C13H13NO2 MW: 215.25 Cas. No: 275826-46-5 | |
CV1802 | Boc-(S)-3-Amino-3-(1-naphthyl)-propionic acid | Form: C18H21NO4 MW: 315.37 Cas. No: 500770-68-3 |
|
CV2802 | Fmoc-(S)-3-Amino-3-(1-naphthyl)-propionic acid | Form: C28H23NO4 MW: 437.49 Cas. No: 507472-10-8 |
|
CV1526 | ethyl (S)-3-amino-3-(1-naphthyl)-propionate | Form: C15H17NO2 MW: 243.31 Cas. No: n.a. |
|
| |||
amines | |||
Prod. No. | Prod. No. | Prod. No. | Prod. No. |
CV0501 | (R)-tetrahydrofurfurylamine [(R)-2-(aminomethyl)tetrahydrofuran] | Form: C5H11NO MW: 101.15 Cas. No: 7202-43-9 e.e.: >98 % | |
CV0502 | (S)-tetrahydrofurfurylamine [(S)-2-(aminomethyl)tetrahydrofuran] | Form: C5H11NO MW: 101.15 Cas. No: 7175-81-7 e.e.: >98 % | |
| |||
|
